Post trial scientists develop tablet to prevent kidney cancer relapse
Washington D.C [USA], Oct. 12 : A recent trial demonstrates that consuming oral tablet Sunitinib for one year reduces the likelihood of cancer returning for kidney cancer patients following removal of the kidney.Reportedly, it is the first ever prevent…